| 12/13/07 |
Sirtris Pharmaceuticals' SIRT1 Activator Controls Glucose as well as a DPP-4 inhibitor in a Pre-Clinical Model of Type 2 Diabetes |
| 12/11/07 |
Sirtris' SIRT 1 Activator Selected by National Institute of Aging for Study of Beneficial Effects on Aging |
| 12/03/07 |
Sirtris Pharmaceuticals to Present at the National Institute of Aging on December 4, 2007 |
| 11/28/07 |
Sirtris and Harvard Unveil Promising, Novel SIRT1 Activators for Treating Diseases of Aging; Therapeutic Type 2 Diabetes Data Published in the Journal Nature |
| 11/26/07 |
Sirtris Pharmaceuticals to Present at the 19th Annual Piper Jaffray, and the Lazard Capital Markets Fourth Annual Healthcare Conferences on November 28, 2007 |
| 11/19/07 |
Leonard P. Guarente Joins Sirtris Pharmaceuticals' Scientific Advisory Board as Co-Chair |
| 11/12/07 |
Sirtris Pharmaceuticals to Present at the JMP Securities Sector Focus Conference on November 13, 2007 |
| 11/12/07 |
Sirtris Pharmaceuticals Reports Third Quarter 2007 Financial Results; Significant Progress Toward 2007 Goals |
| 11/09/07 |
Sirtris Scientific Advisory Board Member Describes a Novel Endogenous SIRT1 Activator |
| 11/02/07 |
Sirtris Pharmaceuticals to Present at the CIBC 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 6, 2007 |
| 11/01/07 |
Sirtris Pharmaceuticals to Present at the JPMorgan SMid Cap Conference on November 5, 2007 |
| 11/01/07 |
Sirtris Pharmaceuticals To Webcast Conference Call for Third Quarter 2007 Financial Results |
| 10/31/07 |
Sirtris Pharmaceuticals To Present at the 3rd Annual Metabolic Diseases World Summit on November 1, 2007 |
| 10/26/07 |
Sirtris Pharmaceuticals' Christoph Westphal Awarded 2007 Mass High Tech All Star Award |
| 10/16/07 |
Sirtris Pharmaceuticals to Present at the 2nd Annual Metabolic Syndrome Forum on October 17, 2007 |
| 10/11/07 |
Sirtris Licenses Fundamental Patent from Guarente Lab at MIT: SIRT1 Activation Has Therapeutic Potential for Lipid Disorders |
| 10/10/07 |
Sirtris Pharmaceuticals To Open NASDAQ Stock Market on October 16, 2007 |
| 10/09/07 |
Sirtris Pharmaceuticals' Oral Drug Candidate SRT501 Shown To Be Neuroprotective: Implications for SIRT1 Activation in Neurodegenerative Eye Disorders |
| 09/25/07 |
Sirtris Pharmaceuticals to Present at the Targeting Obesity Conference: Solutions and Therapeutics on September 27, 2007 |
| 09/20/07 |
Sirtris and Harvard Discover New Mechanism to Slow Aging; Data Published in the Journal Cell |
| 09/13/07 |
Sirtris Pharmaceuticals to Present at the ThinkEquity 5th Annual Growth Conference and Bank of America 37th Annual Investment Conference on September 18, 2007 |
| 09/10/07 |
Sirtris Pharmaceuticals to Present at the Seventh Annual Forbes Global CEO Conference September 12, 2007 |
| 09/06/07 |
National Institute of Aging Funding to Study the Beneficial Effects of SIRT1 Activation on Diseases of Aging |
| 08/21/07 |
Sirtris Pharmaceuticals Initiates Phase 2a Clinical Trial in Patients with Type 2 Diabetes |
| 08/16/07 |
Sirtris Pharmaceuticals and Sirtuin Academic Thought Leaders Publish Review on the Therapeutic Potential of Sirtuins for Diseases of Aging |
| 08/13/07 |
Sirtris Pharmaceuticals Reports Second Quarter 2007 Financial Results; Significant Progress Toward 2007 Goals |
| 08/09/07 |
Sirtris Pharmaceuticals, Inc. Announces Initiation of Phase 1b Clinical Trial of SRT501 in MELAS |
| 08/07/07 |
Sirtris Pharmaceuticals to Webcast Conference Call for Second Quarter 2007 Financial Results |
| 08/02/07 |
Sirtris Pharmaceuticals to Present at the FASEB Summer Research Conferences |
| 07/31/07 |
Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Eye Disorders |
| 07/17/07 |
Sirtris Pharmaceuticals Presents Results of Studies of SIRT1 Activators at 6th Annual Metabolic Diseases Drug Discovery and Development World Summit, July 17, 2007 |
| 07/12/07 |
Sirtris Pharmaceuticals To Present at 6th Annual Metabolic Diseases Drug Discovery and Development World Summit, July 17, 2007 |
| 06/26/07 |
Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimer's Disease |
| 06/25/07 |
Sirtris Pharmaceuticals Added to Russell 3000(R) Index |
| 06/12/07 |
Sirtris Pharmaceuticals to Present at the Sixth Annual Needham & Company Biotechnology and Medical Technology Conference June 13, 2007 |
| 06/07/07 |
Sirtris Pharmaceuticals Named as One of the ''Fierce 15'' Biotech Companies of 2007 |
| 05/30/07 |
Sirtris Pharmaceuticals, Inc. Completes Initial Public Offering |
| 05/25/07 |
Sirtris Pharmaceuticals, Inc. Announces Exercise of Over-Allotment Option by Underwriters |
| 05/23/07 |
Sirtris Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering |
| 03/01/07 |
Sirtris Pharmaceuticals, Inc. Files for Initial Public Offering |
| 01/03/07 |
Sirtris Pharmaceuticals to Present at the 25th Annual JPMorgan Healthcare Conference January 8th 2007 |
